未登录

R

Raman Bahal

University of Connecticut

H指数:31

被引数:4,696

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative analysis of gamma peptide nucleic acid variants in targeting chromosomal DNA

γ肽核酸变体在靶向染色体DNA中的比较分析

Cell Reports Physical Science

IF7.3

2026-04-220

OAAI

Investigating the role of mimosine-induced genotoxic stress through DNA repair profiling

通过DNA修复谱分析研究mimosine诱导的基因毒性应激的作用

Molecular Therapy Nucleic Acids

IF6.1

2026-04-020

OAAI

Combining anti-gene γPNA with small molecules and RNA inhibitors: A strategy to enhance anti-tumor efficacy

结合抗基因 γ pna与小分子和RNA抑制剂: 增强抗肿瘤疗效的策略

MOLECULAR THERAPY NUCLEIC ACIDS

IF6.1

2026-01-210

OAAI

Advances in peptide nucleic acid for targeting RNA and genomic DNA

肽核酸在靶向RNA和基因组DNA方面的进展

Cell Reports Physical Science

IF7.3

2026-01-120

OAAI

Unlocking the alternative chloride pathway in cystic fibrosis

解锁囊性纤维化中的替代氯离子通路

Molecular Therapy

IF12

2025-11-150

PRE

Investigating the crosstalk between ABCC4 and ABCC5 in 3T3-L1 adipocyte differentiation

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2024-12-090

OAAI

Double-stranded DNA invasion by anti-gene oligonucleotide clamps

MOLECULAR THERAPY NUCLEIC ACIDS

IF6.1

2024-12-010

OAAI

Exploring the therapeutic potential of syPNA-141: Pharmacodynamics and mechanistic insights during ischemic stroke recovery

MOLECULAR THERAPY NUCLEIC ACIDS

IF6.1

2024-12-010

OAAI

Efficient and selective kidney targeting by chemically modified carbohydrate conjugates

MOLECULAR THERAPY

IF12

2024-12-011

PRE

Enhancing RNA inhibitory activity using clamp-G-modified nucleobases

CELL REPORTS PHYSICAL SCIENCE

IF7.3

2024-08-011

OAAI

Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs

IF6.9

2024-06-255

PRE

Developing the miR-888 cluster as a therapeutic target for prostate cancer

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Pharmacological Validation of Advanced Gamma Peptide Nucleic Acid (PNA) Based miR Inhibitors for Ischemic Stroke Treatment

IF8.9

2024-02-010

PRE

Antitumor efficacy of a sequence-specific DNA-targeted γPNA-based c-Myc inhibitor

CELL REPORTS MEDICINE

IF10.6

2024-01-014

OAAI

Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin

PHARMACOLOGICAL REVIEWS

IF17.3

2024-01-018

OA

DNA recognition and induced genome modification by a hydroxymethyl-y tail-clamp peptide nucleic acid

CELL REPORTS PHYSICAL SCIENCE

IF7.3

2023-10-013

OA

Head-to-head comparison of in vitro and in vivo efficacy of pHLIP-conjugated anti-seed gamma peptide nucleic acids

CELL REPORTS PHYSICAL SCIENCE

IF7.3

2023-10-013

OA

microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis

IF6.1

2023-02-2232

OA

Ahangari, Farida; Price, Nathan L.; Malik, Shipra; Chioccioli, Maurizio; Barnthaler, Thomas; Adams, Taylor S.; Kim, Jooyoung; Pradeep, Sai Pallavi; Ding, Shuizi; Cosmos Jr., Carlos; Rose, Kadi-Ann S.; McDonough, John E.; Aurelien, Nachelle R.; Ibarra, Gabriel; Omote, Norihito; Schupp, Jonas C.; DeIuliis, Giuseppe; Nunez, Julian A. Villalba; Sharma, Lokesh; Ryu, Changwan; Dela Cruz, Charles S.; Liu, Xinran; Prasse, Antje; Rosas, Ivan; Bahal, Raman; Fernandez-Hernando, Carlos; Kaminski, Naftali

Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy

SCIENCE ADVANCES

IF12.5

2023-02-1021

OAAI

Multivalent Lactobionic Acid and N-Acetylgalactosamine-Conjugated Peptide Nucleic Acids for Efficient In Vivo Targeting of Hepatocytes

ADVANCED HEALTHCARE MATERIALS

IF9.6

2023-01-206

OA